AstraZeneca has officially changed the name of its COVID-19 vaccine AstraZeneca has now registered the brand name Vaxzevria for its COVID-19 vaccine. The TGA approved the name change on Thursday for the product previously named COVID-19 Vaccine AstraZeneca. It is estimated that supply in Australia of the Vaxzevria-branded product will commence in late 2021. Once supply of
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.